Strangvac, a vaccine against equine strangles released for sales in Germany, France, Austria and the Benelux

Stockholm, October 12th, 2022 - Intervacc AB (publ) announces today that the first batch of Strangvac for sale in Germany, France, Austria, Belgium, Luxemburg and the Netherlands has been released.

"The first batch of Strangvac for Germany, France, Austria, Belgium, Luxemburg and the Netherlands has now been released. This means that sales of Strangvac in these countries can begin shortly", explains Andreas Johansson, Logistics Manager at Intervacc.

"Strangvac is approved for sale and marketing in the EU as well as the UK, Norway and Iceland, and has been launched in Sweden, Denmark and in the UK. France, Germany, and the Benelux region are among the largest markets in Europe for equine vaccines. Outbreaks of equine strangles occur regularly and is the cause of great suffering and costs in these regions and across Europe. With the release, we have a finished product approved for launch in these countries. This is significant milestone for our continued launch around Europe." comments Andreas Andersson, CEO of Intervacc.

For more information please contact:  

Andreas Andersson, CEO

Phone: [phone], cell [phone]
E-mail: [e-mail]

This information is information that Intervacc AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above on October 12, 2022.

About Intervacc

Intervacc AB is a Swedish company within animal health developing safe, effective vaccines for animals. The Company's vaccine and vaccine candidates are based on several years of research at Karolinska Institutet and Swedish University of Agricultural Research where the foundation was laid for the Company´s research and development work. The Intervacc share has been listed on the Nasdaq First North Growth Market since April 2017 with Eminova Fondkommission AB, [e-mail], [phone] as Certified Adviser.

 

Contact information for Certified Adviser

Eminova Fondkommission AB

E-mail: [e-mail], Phone: +46 (0)8 - 684 211 10

https://news.cision.com/intervacc/r/strangvac--a-vaccine-against-equine-strangles-released-for-sales-in-germany--france--austria-and-the,c3647041

https://mb.cision.com/Main/4632/3647041/1637750.pdf

https://news.cision.com/intervacc/i/lntervacc-,c3099988

(c) 2022 Cision. All rights reserved., source Press Releases - English